Healthcare costs for new technologies

被引:32
作者
Goyen, Mathias [1 ]
Debatin, Joerg F. [1 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, D-20251 Hamburg, Germany
关键词
Healthcare costs; Medical technology; Health policy; Cost drivers; Health spending; FDG-PET; MANAGEMENT;
D O I
10.1007/s00259-008-0975-y
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Continuous ageing of the population coupled with growing health consciousness and continuous technological advances have fueled the rapid rise in healthcare costs in the United States and Europe for the past several decades. The exact impact of new medical technology on long-term spending growth remains the subject of controversy. By all measures it is apparent that new medical technology is the dominant driver of increases in health-care costs and hence insurance premiums. This paper addresses the impact of medical technology on healthcare delivery systems with regard to medical practice and costs. We first explore factors affecting the growth of medical technology and then attempt to provide a means for assessing the effectiveness of medical technology. Avoidable healthcare cost drivers are identified and related policy issues are discussed.
引用
收藏
页码:139 / 143
页数:5
相关论文
共 8 条
[1]  
*ADVAMED, 2004, VAL INV HLTH CAR BET
[2]   Health care spending and use of information technology in OECD countries [J].
Anderson, GF ;
Frogner, BK ;
Johns, RA ;
Reinhardt, UE .
HEALTH AFFAIRS, 2006, 25 (03) :819-831
[3]  
*CTR MED MED SERV, 2008, NAT HLTH EXP DAT
[4]   TGhe value of medical spending in the United States, 1960-2000 [J].
Cutler, David M. ;
Rosen, Allison B. ;
Vijan, Sandeep .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (09) :920-927
[5]   Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results [J].
Dietlein, M ;
Weber, K ;
Gandjour, A ;
Moka, D ;
Theissen, P ;
Lauterbach, KW ;
Schicha, H .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (11) :1598-1609
[6]   Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany [J].
Dietlein, M ;
Weber, K ;
Gandjour, A ;
Moka, D ;
Theissen, P ;
Lauterbach, KW ;
Schicha, H .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (10) :1441-1456
[7]   MEDICAL-CARE COSTS - HOW MUCH WELFARE LOSS [J].
NEWHOUSE, JP .
JOURNAL OF ECONOMIC PERSPECTIVES, 1992, 6 (03) :3-21
[8]  
RETTIG RA, 1994, HLTH AFFAIRS, V15